Codeine Phosphate (Codeine Phosphate)



Indications and Reactions:

Role Indications Reactions
Primary
Abdominal Pain Upper 100.0%
Overdose 50.0%
Pancreatitis 50.0%
Secondary
Migraine 19.4%
Osteoarthritis 19.4%
Asthma 12.9%
Ill-defined Disorder 8.6%
Drug Use For Unknown Indication 7.9%
Hypothyroidism 7.2%
Deep Vein Thrombosis 6.5%
Epilepsy 5.8%
Nasopharyngitis 5.0%
Pain 2.2%
Product Used For Unknown Indication 2.2%
Bronchopneumonia 1.4%
Tonsillitis 1.4%
Dyspnoea 47.1%
Emergency Care Examination Abnormal 5.9%
Inappropriate Schedule Of Drug Administration 5.9%
Intentional Overdose 5.9%
Pancreatitis Acute 5.9%
Respiratory Rate Decreased 5.9%
Small Intestinal Perforation 5.9%
Stevens-johnson Syndrome 5.9%
Therapy Non-responder 5.9%
Toxic Epidermal Necrolysis 5.9%
Concomitant
Lung Adenocarcinoma 15.9%
Product Used For Unknown Indication 11.9%
Depression 10.1%
General Anaesthesia 7.9%
Multiple Myeloma 7.9%
Lung Squamous Cell Carcinoma Stage Unspecified 5.3%
Osteoporosis 5.3%
Induction Of Anaesthesia 4.4%
Pancreatic Carcinoma Metastatic 3.5%
Prophylaxis Of Nausea And Vomiting 3.5%
Maintenance Of Anaesthesia 3.1%
Neuralgia 3.1%
Parkinson's Disease 3.1%
Non-small Cell Lung Cancer 2.6%
Hypertension 2.2%
Lower Respiratory Tract Infection 2.2%
Musculoskeletal Pain 2.2%
Non-small Cell Lung Cancer Metastatic 2.2%
Adenosquamous Cell Lung Cancer 1.8%
Cardiac Failure 1.8%
Rash 11.0%
Vomiting 8.2%
Gastrointestinal Haemorrhage 6.8%
Pneumothorax 6.8%
Respiratory Failure 6.8%
Oedema Peripheral 5.5%
Pneumonia 5.5%
Rhabdomyolysis 5.5%
White Blood Cell Count Increased 5.5%
Drug Exposure During Pregnancy 4.1%
International Normalised Ratio Increased 4.1%
Renal Failure Acute 4.1%
Skin Ulcer 4.1%
Sputum Culture Positive 4.1%
Toxic Epidermal Necrolysis 4.1%
Agranulocytosis 2.7%
Duodenal Ulcer Perforation 2.7%
Dyspnoea 2.7%
Erectile Dysfunction 2.7%
Haematemesis 2.7%